children with CKD Vitamin D3 Hepcidin Interleukin-6 Chronic Kidney Disease Children
Conditions
Interventions
GFR greater than or equal to 90 mL per min per 1.73 m,GFR less than 90 mL per min per 1.73 m
Screening,Screening
Sponsors
Self-funding
Eligibility
Sex/Gender
All
Age
2 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1. Children aged 2 to 18 years. 2. Diagnosed with chronic kidney disease (CKD). 3. Recruited from the pediatric nephrology inpatient and outpatient wards at our Inst
Exclusion criteria
Exclusion criteria: Exclusion Criteria: 1. Children with malignancy. 2. Children who have received a blood transfusion within the past 3 months. 3. Children with a history of bleeding within the past 3 months. 4. Children with liver dysfunction. 5. Children currently experiencing an infectious disease. 6. Children who have previously or are currently consuming vitamin D3 supplements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vitamin D, Hepcidin, and Interleukin-6 levels All participants underwent examinations for urea, creatinine, serum vitamin D, hepcidin, and IL-6 levels both before and after vitamin D3 supplementation at a dose of 2,000 IU per day for 6 weeks ng/mL | — |
Secondary
| Measure | Time frame |
|---|---|
| Characteristic data, Characteristic data is to be recorded after vitamin D3 supplementation at a dose of 2,000 IU per day for 6 weeks. age, sex, ,Nutritional status, Comorbid Nutritional status and comorbid data is to be recorded after vitamin D3 supplementation at a dose of 2,000 IU per day for 6 weeks. Underweight, Normal weight, and Overweight | — |
Countries
Indonesia
Contacts
Public ContactNicholas Redly
Department of Pediatrics, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Outcome results
None listed